Jun 2026 (Q2 FY26) — Aug 5, 2026
Horizon Technology Finance Q2 FY26 – Merger Integration and Portfolio Growth Amidst Write-Downs
Read the full callHorizon Technology Finance earnings: last reported Wed, 5 Aug 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | Quarterly, as filed | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. | ||
| Operating margin | Operating profit / revenue | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. | ||
| Net profit | -37.3 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
1Y: $5.85 on 17 Oct 2025 → $4.11. High $6.81 (11 Nov 2025), low $3.87 (27 Apr 2026).
Overview
Call summaries
Horizon Technology Finance Q2 FY26 – Merger Integration and Portfolio Growth Amidst Write-Downs
Read the full callEvery analysed call
Financials
Net profit, year on year: −79% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Expenses | 12 | 13 | 13 | 13 | 12 | 12 | 15 | 17 |
| Interest | 8 | 8 | 9 | 8 | 8 | 8 | 8 | 8 |
| Net profit | 7 | -12 | -21 | -21 | 31 | 9 | 3 | -37 |
| EPS ($ per share) | 0.20 | — | -0.53 | -0.50 | 0.71 | — | 0.06 | -0.57 |
| Line item | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 |
| Reserves | -56 | -68 | -127 | -182 | -241 |
| Total liabilities | 269 | 448 | 478 | 486 | 493 |
| Total assets | 514 | 767 | 802 | 822 | 811 |
| Line item | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Cash from operations | -25 | -76 | -246 | -5 | 4 | 57 |
| Cash from financing | 56 | 76 | 229 | 51 | 21 | -15 |
| Net cash flow | 30 | -0 | -17 | 45 | 25 | 42 |
10 filings between Apr 14, 2026 and Jun 10, 2026.
Purchases
$629.6K
6 purchases by 6 insiders
Sales
None
No insider sold shares.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Balkin Michael | $434.0K | — | Jun 9, 2026 |
| Seitz Paul G | $49.9K | — | Jun 9, 2026 |
| Trolio Daniel R. | $49.9K | — | Jun 10, 2026 |
| O'Connor Kimberley Ann | $43.7K | — | Jun 9, 2026 |
| ALLISON THOMAS J. | $26.2K | — | Jun 9, 2026 |
| Goodman Jonathan Joseph | $25.9K | — | Jun 9, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Jun 10, 2026 | Trolio Daniel R. Executive VP and CFO | Purchase | 11,500 | $49.9K |
| Jun 9, 2026 | O'Connor Kimberley Ann Director | Purchase | 10,000 | $43.7K |
| Jun 9, 2026 | ALLISON THOMAS J. Director | Purchase | 6,000 | $26.2K |
| Jun 9, 2026 | Balkin Michael Chief Executive Officer | Purchase | 100,000 | $434.0K |
| Jun 9, 2026 | Seitz Paul G Chief Investment Officer | Purchase | 11,477 | $49.9K |
| Jun 9, 2026 | Goodman Jonathan Joseph Director | Purchase | 6,000 | $25.9K |
| Apr 14, 2026 | Balkin Michael Chief Executive Officer | Award | 93,527 | — |
| Apr 14, 2026 | ALLISON THOMAS J. Director | Award | 49,926 | — |
| Apr 14, 2026 | Balkin Michael Chief Executive Officer | Award | 93,527 | — |
| Apr 14, 2026 | Seitz Paul G Chief Investment Officer | Award | 142 | — |
| Dec 16, 2024 | Balkin Michael Director | Purchase | 20,000 | $170.6K |
| Nov 25, 2024 | Michaud Gerald A. President | Purchase | 8,000 | $74.5K |
| Nov 14, 2024 | SAVAGE JOSEPH J Director | Purchase | 4,500 | $41.4K |
| Nov 13, 2024 | SAVAGE JOSEPH J Director | Purchase | 5,000 | $46.8K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow Horizon Technology Finance Corp and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading